First, this monoclonal antibody recognizes a neoepitope on domain I of bound β2GPI, regarded as the main target of pathogenic aPL antibodies responsible for thrombosis and fetal loss in animal models of APS (7, 14, 18, 33). The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.